As advanced therapies scale, manufacturers are rethinking how they bring products to market and who they rely on to get there.
Alina Chesnokova
Advertisement
Alina Chesnokova is a Vice President, Global Commercialization for Cencora’s 3PL businesses, Alloga and ICS. Her scope includes all commercial activities across Europe and the U.S., including business development, implementation of new clients, and key account management. In addition to that, Alina supports new solutions development and building integrated offerings with other Cencora businesses.
Alina joined Cencora in 2023, as a Senior Director Executive Management overseeing execution of the key strategic priorities across Cencora’s 3PL businesses. Alina brings over 15 years of expertise in corporate strategy, healthcare, and pharmaceutical consulting.
Articles by Alina Chesnokova
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
2
Novartis to Acquire Myricx Bio for $1.1 Billion
3
How Regulatory Stringency, Demand Shocks, and Repurposing Reshape Biopharma Strategy in 2026
4
Traditional Healthcare Has a Retention Problem It Refuses to Diagnose
5